ASLAN Pharmaceuticals (ASLN) Stock News, Jul-Nov 2023

ASLN Nasdaq

11/20/2023 07:00 AM

News

ASLAN Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

-

11/03/2023 07:00 AM

News

ASLAN Pharmaceuticals Presents New Data on Eblasakimab in Atopic Dermatitis and COPD Translational Models at the 7th Dermatology Drug Development Summit

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

3.77%

Tags

-

10/27/2023 08:00 AM

News

ASLAN Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-10.5%

Tags

10/24/2023 08:00 AM

News

ASLAN Pharmaceuticals to Co-Host KOL Panel Discussion Today on Changes in the Clinical Trial and Treatment Landscape for Atopic Dermatitis

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

2.56%

Tags

-

10/18/2023 07:00 AM

News

ASLAN Pharmaceuticals to Co-Host KOL Panel Discussion on Changes in the Clinical Trial and Treatment Landscape for Atopic Dermatitis

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

4.65%

Tags

-

10/13/2023 09:30 AM

News

ASLAN Pharmaceuticals Presents New Data From Phase 2b Study of Eblasakimab in Atopic Dermatitis in Late Breaker Presentation at 32nd European Academy of Dermatology and Venereology Congress

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-10.49%

Tags

09/22/2023 07:00 AM

News

ASLAN Pharmaceuticals Announces Acceptance of Late Breaker Abstract on Eblasakimab Phase 2b Results as Oral Presentation and Three Additional Abstracts at 32nd European Academy of Dermatology and Venereology Congress

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.01%

Tags

-

09/07/2023 07:00 AM

News

ASLAN Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-2.83%

Tags

-

08/11/2023 07:00 AM

News

ASLAN Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

0.46%

Tags

07/06/2023 07:55 AM

News

Eblasakimab Monthly Dosing Shows Potential for Best-In-Class Therapy in Positive Phase 2b Study in Atopic Dermatitis

Rhea-AI Summary

Summary not available.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-24.41%

Tags

FAQ

What is the current stock price of ASLAN Pharmaceuticals (ASLN)?

ASLAN Pharmaceuticals (ASLN) last closed at $0.6.

What is the market cap of ASLAN Pharmaceuticals (ASLN)?

The market cap of ASLAN Pharmaceuticals (ASLN) is approximately $1.7M.